http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007017546-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7139811dadf0725c8f6093aaa638db97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e19ed5092514d4f22acfa3bc98b8b572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966480af70de9ec89a21b5035d89da34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
filingDate 2006-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cc74008db525e9d856734f0e0e75718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72b09ac6509cfceba694091b6e83064c
publicationDate 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007017546-A3
titleOfInvention Method of obtaining tryptamine derivatives
abstract The invention relates to a method of obtaining tryptamine derivatives (I), wherein R is a radical of a heterocycle, comprising the decarboxylation of the corresponding derivative of 3-(2-aminoethyl)-1H-indole carboxylic acid and the subsequent methylation of the amino group. Compounds (I) include zolmitriptan and rizatriptan which can be used for the treatment of migraines.
priorityDate 2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0497512-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2204302-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69396073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228160436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231146931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID687975

Total number of triples: 44.